AU2003251671A1 - Intravenous pharmaceutical form of administration - Google Patents

Intravenous pharmaceutical form of administration

Info

Publication number
AU2003251671A1
AU2003251671A1 AU2003251671A AU2003251671A AU2003251671A1 AU 2003251671 A1 AU2003251671 A1 AU 2003251671A1 AU 2003251671 A AU2003251671 A AU 2003251671A AU 2003251671 A AU2003251671 A AU 2003251671A AU 2003251671 A1 AU2003251671 A1 AU 2003251671A1
Authority
AU
Australia
Prior art keywords
administration
pharmaceutical form
intravenous pharmaceutical
intravenous
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003251671A
Inventor
Johannes Bartholomaus
Heinrich Kugelmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of AU2003251671A1 publication Critical patent/AU2003251671A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
AU2003251671A 2002-07-30 2003-07-30 Intravenous pharmaceutical form of administration Abandoned AU2003251671A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2002134784 DE10234784A1 (en) 2002-07-30 2002-07-30 Pharmaceutical dosage form that can be administered intravenously
DE10234784.0 2002-07-30
PCT/EP2003/008421 WO2004012708A1 (en) 2002-07-30 2003-07-30 Intravenous pharmaceutical form of administration

Publications (1)

Publication Number Publication Date
AU2003251671A1 true AU2003251671A1 (en) 2004-02-23

Family

ID=30469224

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003251671A Abandoned AU2003251671A1 (en) 2002-07-30 2003-07-30 Intravenous pharmaceutical form of administration

Country Status (5)

Country Link
EP (1) EP1526838B8 (en)
AU (1) AU2003251671A1 (en)
DE (1) DE10234784A1 (en)
ES (1) ES2389837T3 (en)
WO (1) WO2004012708A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
EP3843703A1 (en) 2018-08-28 2021-07-07 GSK Consumer Healthcare S.A. Paracetamol liquid suspensions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60208910A (en) * 1984-03-31 1985-10-21 Green Cross Corp:The Preparation of composite of hardly water-soluble drug and phospholipid
DE3682130D1 (en) * 1985-07-15 1991-11-28 Japan Res Dev Corp METHOD FOR PRODUCING ULTRAFINE ORGANIC COMPOUNDS.
DE3623376A1 (en) * 1986-07-11 1988-01-21 Behringwerke Ag PHARMACEUTICAL FORMULATION AND METHOD FOR THE PRODUCTION THEREOF
NL194638C (en) * 1986-12-19 2002-10-04 Novartis Ag Hydrosol containing solid particles of a pharmaceutically active substance and pharmaceutical preparation containing this hydrosol.
NL9000634A (en) * 1990-03-20 1991-10-16 Catharina Ziekenhuis Stichting WATER-BASED SUSPENSION INJECTION PREPARATION, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THIS PREPARATION FOR PAIN RELIEF.
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5785976A (en) * 1993-03-05 1998-07-28 Pharmacia & Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
IL115099A (en) * 1994-10-14 1999-04-11 Upjohn Co Lyophilizate of phospholipid complex of water insoluble camptothecins
DE4440337A1 (en) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmaceutical nanosuspensions for drug application as systems with increased saturation solubility and dissolution rate
US5510118A (en) * 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
BRPI9810945B8 (en) * 1997-06-27 2021-05-25 Abraxis Bioscience Inc formulations of pharmacological agents, methods for their preparation and methods for using them
US6337092B1 (en) * 1998-03-30 2002-01-08 Rtp Pharma Inc. Composition and method of preparing microparticles of water-insoluble substances

Also Published As

Publication number Publication date
WO2004012708A1 (en) 2004-02-12
EP1526838B1 (en) 2012-08-22
EP1526838B8 (en) 2013-02-06
DE10234784A1 (en) 2004-02-19
EP1526838A1 (en) 2005-05-04
ES2389837T3 (en) 2012-11-02

Similar Documents

Publication Publication Date Title
AU2003211376A1 (en) Drug administration method
AU2003301957A1 (en) Administration of anti-inflammatory drugs into the central nervous system
AU2003296897A1 (en) Pharmaceutical formulations of camptothecine derivatives
AU2003272590A1 (en) Method for ophtalmic administration of medicament
AU2002357012A1 (en) Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
AU2002342050A1 (en) Anesthesia drug monitor
AU2003303633A1 (en) Fast dissolving films for oral administration of drugs
IL163831A0 (en) Derivatives of aminoindazoles, method of preparation and intermediates of the method as drugs pharmaceutical compounds containing
AU2003298841A1 (en) Pharmaceutical compositions containing indistinguishable drug components
HUP0400200A3 (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
IL169083A (en) Medication administration system
AU2003223005A1 (en) Application device for topical administration of pharmaceutical agents
AU2003246978A1 (en) Pharmaceutical compositions comprising cyclosporin for oral administration
AU2003226189A1 (en) Oral administration of epothilones
AU2003245504A1 (en) Pharmaceutical compositions for drugs having ph-dependentsolubility
IL166337A0 (en) Oral administration of calctionin
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2002346143A1 (en) Compositions for nasal administration of insulin
AU2003250317A1 (en) Device for administration of fluids
AU2003257982A1 (en) Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
EP1526838B8 (en) Intravenous pharmaceutical form of administration
AUPS286302A0 (en) Medication inhaler
AU2003284786A1 (en) Microemulsion composition for oral administration of biphenyldimethyldicarboxylate
AU2003296385A1 (en) Therapeutic single dose gas administration system
AU2003251643A1 (en) Pharmaceutical compositions containing keto-acids for endoperitoneal administration